ProPhase Labs Inc (PRPH)
2.19
+0.05
(+2.34%)
USD |
NASDAQ |
Nov 04, 16:00
2.19
0.00 (0.00%)
After-Hours: 20:00
ProPhase Labs Total Liabilities (Quarterly): 49.60M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 49.60M |
| March 31, 2024 | 45.16M |
| December 31, 2023 | 42.54M |
| September 30, 2023 | 35.28M |
| June 30, 2023 | 31.80M |
| March 31, 2023 | 35.43M |
| December 31, 2022 | 24.02M |
| September 30, 2022 | 29.96M |
| June 30, 2022 | 29.79M |
| March 31, 2022 | 33.22M |
| December 31, 2021 | 30.67M |
| September 30, 2021 | 24.37M |
| June 30, 2021 | 28.59M |
| March 31, 2021 | 32.78M |
| December 31, 2020 | 20.85M |
| September 30, 2020 | 12.27M |
| June 30, 2020 | 1.481M |
| March 31, 2020 | 1.237M |
| December 31, 2019 | 1.043M |
| September 30, 2019 | 1.202M |
| June 30, 2019 | 1.147M |
| March 31, 2019 | 0.87M |
| December 31, 2018 | 4.233M |
| September 30, 2018 | 0.876M |
| June 30, 2018 | 1.595M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.10M |
| December 31, 2017 | 1.812M |
| September 30, 2017 | 2.432M |
| June 30, 2017 | 3.473M |
| March 31, 2017 | 6.873M |
| December 31, 2016 | 6.84M |
| September 30, 2016 | 6.253M |
| June 30, 2016 | 5.177M |
| March 31, 2016 | 5.831M |
| December 31, 2015 | 6.00M |
| September 30, 2015 | 3.815M |
| June 30, 2015 | 3.677M |
| March 31, 2015 | 5.624M |
| December 31, 2014 | 5.341M |
| September 30, 2014 | 7.382M |
| June 30, 2014 | 6.152M |
| March 31, 2014 | 4.464M |
| December 31, 2013 | 4.824M |
| September 30, 2013 | 5.041M |
| June 30, 2013 | 4.771M |
| March 31, 2013 | 4.164M |
| December 31, 2012 | 5.21M |
| September 30, 2012 | 6.643M |
| June 30, 2012 | 6.403M |
| March 31, 2012 | 7.296M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.043M
Minimum
Dec 2019
49.60M
Maximum
Jun 2024
26.85M
Average
29.96M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Fonar Corp | 57.46M |
| XWELL Inc | 19.06M |
| Applied DNA Sciences Inc | 4.456M |
| Veracyte Inc | 101.80M |
| OncoCyte Corp | 52.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.68M |
| Shareholders Equity (Quarterly) | 44.08M |
| Debt to Equity Ratio | 0.3083 |
| Current Ratio | 1.576 |
| Net Debt Paydown Yield | -0.99% |